We are live on ! Find out more
IDXX icon

Idexx Laboratories

1,032 hedge funds and large institutions have $46.1B invested in Idexx Laboratories in 2021 Q2 according to their latest regulatory filings, with 106 funds opening new positions, 332 increasing their positions, 382 reducing their positions, and 72 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more funds holding in top 10

Funds holding in top 10: 2539 (+14)

47% more first-time investments, than exits

New positions opened: 106 | Existing positions closed: 72

30% more capital invested

Capital invested by funds: $35.6B → $46.1B (+$10.5B)

2% more funds holding

Funds holding: 1,0111,032 (+21)

0.52% more ownership

Funds ownership: 85.26%85.79% (+0.52%)

13% less repeat investments, than reductions

Existing positions increased: 332 | Existing positions reduced: 382

37% less call options, than puts

Call options by funds: $147M | Put options by funds: $232M

Holders
1,032
Holders Change
+21
Holders Change %
+2.08%
% of All Funds
17.96%
Holding in Top 10
39
Holding in Top 10 Change
+14
Holding in Top 10 Change %
+56%
% of All Funds
0.68%
New
106
Increased
332
Reduced
382
Closed
72
Calls
$147M
Puts
$232M
Net Calls
-$85.2M
Net Calls Change
+$27M

IDXX Hedge Fund Activity: Q2 2021 in Review

1,032 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q2 2021, worth a combined $46.1B — up 30% from $35.6B a quarter earlier.

Buyers outnumbered sellers: 106 funds opened new IDXX positions and 72 closed out — a net gain of 34 holders — while 332 added to existing stakes and 382 trimmed.

The largest buyer was BlackRock, adding an estimated $242M. The largest seller was T. Rowe Price Associates, cutting an estimated $300M.

  • 1,032 institutional investors held Idexx Laboratories (IDXX) as of Q2 2021, up from 1,011 in Q1 2021.
  • Funds reported $46.1B of Idexx Laboratories stock for Q2 2021, up 30% quarter-over-quarter.
  • 106 funds opened new Idexx Laboratories positions in Q2 2021 and 72 closed out, a net change of +34 holders.
  • The largest Idexx Laboratories buyer in Q2 2021 was BlackRock, an estimated $242M added.
  • The largest Idexx Laboratories seller in Q2 2021 was T. Rowe Price Associates, an estimated $300M sold.

Based on aggregated 13F filings for Q2 2021.